John has been involved in Logica since 2023 and is a director in small molecule drug discovery with Charles River, which he joined in 2014. John provides scientific and operational oversight and leadership for Logica and Charles River integrated drug discovery client projects as well as contributing to the leadership of the chemistry department. John has over 22 years’ experience in drug discovery as a medicinal chemist and has successfully led teams working across Hit-ID to candidate selection in different therapeutic areas, including neuroscience, oncology, inflammation and rare diseases, across a range of target classes. Prior to working at Charles River, he spent 12 years working for biotech and pharmaceutical companies, including Eisai and Millennium Pharmaceuticals. He obtained his first degree and Ph.D. at the University of Warwick and undertook postdoctoral research at the University of Southampton. John is a co-author or co-inventor on 28 patents and publications.